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Ambulatory Chemotherapy 
The provision of chemotherapy infusions to patients on an 
ambulatory basis using a portable infusion device1 
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Patient testimonial 
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Elastomeric Infusion Pumps 
PUMP COMPONENTS 
(4) Having chemo by chemotherapy pump, 2015, digital phototgraph, Chemotherapy Pumps, Cancer research UK, Accessed on 2 July 2014, http://www.cancerresearchuk.org/about-
cancer/cancers-in-general/treatment/chemotherapy/having/chemotherapy-pumps 
(5) Pressure, 2014, digital photograph and vector, Summit Medical Products Ambit Infusion Pumps, http://ambitpump.com/pressure-concepts 
(6) Baxter Elastomeric Pumps. Clinician Guide”. Baxter. Health Technology Safety Research Team. N.d. Web. Retrieved July 1st 2014 from: http://www.capca.ca/wp-
content/uploads/Baxter-Elastomeric-Pumps-Clinician-Guide11.pdf 
-Outer protective shell 
- Inner elastomeric “balloon” 
continuously deflating and driving 
the liquid through the IV line 
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Elastomeric Infusion Pumps 
(7) Elastomeric Pump 100ml Volume 0.5 ml / hr. Vector. Accessed on May 20th 2015. www.shopmedvet.com 
(8) Dosi fuser pump. vector. Accessed on May 21st 2015. www.omnimedicalsupply.com 
PUMP COMPONENTS 
Pump A Pump B 
Ambulatory chemotherapy: what community and hospital pharmacists need to know 
| Racha Sabbagh Dit Hawasli, Pharm.D, PhD candidate | Friday 5th June 2015 
(9) Baxter folfusor 2ml/hr: BAXTER FOLFUSOR SV 2 ML/H 48 HR. Digital photograph. Accessed on May 21st 2015. www.absolutmedicalhealthcare.com 
(10) Baxter folfusor 2.5ml/hr: BAXTER FOLFUSOR SV 2,5 ML/H 2 DAYS. Digital photograph. Accessed on May 21st 2015. www.absolutmedicalhealthcare.com 
(11) Baxter folfusor 5ml/hr: BAXTER FOLFUSOR SV 5 ML/H 1 DIA. Digital photograph. Accessed on May 21st 2015. www.absolutmedicalhealthcare.com 
Elastomeric Infusion Pumps 
Different capacities and flow rates to suit all regimens 
120 mL 
120 mL 96 mL 
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Applications 
• Infusing antibiotic, pain management 
medication, iron chelation, chemotherapy 
• Some chemotherapy protocols provided on 
ambulatory basis: 5FU, Ifosfamide+Mesna, 
Trabectidin, etc. 
Elastomeric Infusion Pumps 
(12) Romain Coriat, Olivier Mir. (2010) Ambulatory administration of 5-day infusion ifosfamide + mesna: a pilot study in sarcoma patients. Cancer chemotherapy and pharmacology, 65(3), 
491-495. 
(13) Michael Rubino, James M. Hoffman .Schöffski P, Cerbone L, Wolter P, De Wever I, Samson I, Dumez H, Clement P, Wildiers H, Stas M. Administration of 24-h intravenous infusions of 
trabectedin in ambulatory patients with mesenchymal tumors via disposable elastomeric pumps: an effective and patient-friendly palliative treatment option. Onkologie. 2012;35(1-2):14-7. 
doi: 10.1159/000335879. Epub 2012 Jan 20. 
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Elastomeric Infusion Pumps 
Advantages Disadvantages 
No programming/easy set up Flow rate +/- 15% 
Portable Infusion rate dependent on 
external factors 
Light weight 
Discreet, Silent operation 
Disposable 
No alarm 
(14) Elena A. Skryabina; Teresa S. Dunn. (2006) Disposable Infusion Pumps. Am J Health-Syst Pharm, 63(13):1260-1268 
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Factors affecting infusion rate 
(6) Baxter Elastomeric Pumps. Clinician Guide”. Baxter. Health Technology Safety Research Team. N.d. Web. Retrieved July 1st 2014 from: http://www.capca.ca/wp-content/uploads/Baxter-
Elastomeric-Pumps-Clinician-Guide11.pdf 
(13) Michael Rubino, James M. Hoffman .Schöffski P, Cerbone L, Wolter P, De Wever I, Samson I, Dumez H, Clement P, Wildiers H, Stas M. Administration of 24-h intravenous infusions of 
trabectedin in ambulatory patients with mesenchymal tumors via disposable elastomeric pumps: an effective and patient-friendly palliative treatment option. Onkologie. 2012;35(1-2):14-7. doi: 
10.1159/000335879. Epub 2012 Jan 20. 
Temperature ~ body 
temperature 
Luer Lock/Capillary 
element taped to skin 
Fill volume Up to pump 
Capacity 
mL/hr infusion rate 
Viscosity of the 
solution 
Dextrose 5% 
Or 0.9% NaCl 
Check manufacturer’s 
guide 
Pressure Ambient Caution in 
Hyperbaric/Hypobaric 
conditions 
Pump Height Luer Lock 
connector 
Caution during sleep 
and carrying 
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Elastomeric Infusion Pumps 
(15) Elastomeric Pump 100ml Volume 0.5 ml / hr. Vector. Accessed on May 20th 2015. www.shopmedvet.com 
(16) Dosi fuser pump. vector. Accessed on May 21st 2015. www.omnimedicalsupply.com 
PUMP COMPONENTS 
Pump A Pump B 
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Factors affecting infusion rate 
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Current use 
 Used for over 20 years11  
 Merits: 
Safe 12, 13 
Effective 13 
Preferred by patients 1, 13, 14 
 
 
 (21) Lokich JJ, Perri J, Bothe A., et.al. Cancer chemotherapy via ambulatory infusion pump. Am J Clin Oncol. 1983 Jun;6(3):355-63 
(22) François Lüthi. Nadia Fucina. Nathalie Divorne. Brigitte Santos-Eggimann. Christine Currat-Zweifel. Patricia Rollier, et al.(2012). Home care—a safe and attractive alternative to inpatient 
administration of intensive chemotherapies. Support Care Cancer; 20:575–581 
(23) Michael Rubino, James M. Hoffman et. al. Administration of 24-h intravenous infusions of trabectedin in ambulatory patients with mesenchymal tumors via disposable elastomeric pumps: 
an effective and patient-friendly palliative treatment option. Onkologie. 2012;35(1-2):14-7. doi: 10.1159/000335879. Epub 2012 Jan 20. 
(24) Joo EH, Rha SY, Ahn JB, et al. Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital based chemotherapy for patients with colorectal cancer. 
Support Care Cancer (2011) 19:971–978 
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Impact 
EFFECT ON HOSPITAL 
Reduced bed occupancy 17 Reduced hospital work load 1 
EFFECT ON PATIENT 
Reduced chance of encountering 
nosocomial infections14, 15 Improved quality of life 
15, 16 
AMBULATORY CHEMOTHERAPY 
Prevents hospital admission Waives cost of hospital stay 13,14 
(25) Eun-Hye Joo & Sun-Young Rha. Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer. 
Support Care Cancer (2011) 19:971–978 
(26) Hospital Epidemiology and Infection Control in Acute-Care Settings. CLINICAL MICROBIOLOGY REVIEWS, Jan. 2011, WHO [Internet] World health Organization 2002. Prevention of 
hospital acquired infection. A practical guide, 2nd edition 
(27) Michelle Rowe,1 Juan W Valle. New face for a familiar friend: the deGramont regimen in the treatment of metastatic colorectal cancer given as an outpatient: a feasibility study. J Oncol 
Pharm Practice (2002) 8: 97 – 103 
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Use in Lebanon 
(28) Marco Tampellini. (2010) Pharmacoeconomic aspects of FOLFIRI or FOLFOX regimens administered with a fully ambulatory pump compared to the day hospital setting. Tumori, 
96: 438-442 
 Use in colon cancer regimens 
 
 Hospital based  FOLFOX and FOLFIRI protocols 
 
 
 
 
 
 
Folinic acid 
Fluorouracil
(5FU) 
Oxaliplatin 
Irinotecan 
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FOLFOX6 FOLFIRI pathway for 
ambulatory treatment 
(29) Tournigand, C, Andre. T, Achille E., et. al. FOLFIRI Followed By FOLFOX6 Or The Reverse Sequence In Advanced Colorectal Cancer: A Randomized GERCOR Study. Journal of 
Clinical Oncology 22.2 (2003): 229-237 
(A)Simplified leucovorin (l -LV) and fluorouracil (FU) every 2 weeks (LVFU2) plus irinotecan 
(FOLFIRI) 
(B) simplified LVFU2 plus oxaliplatin (FOLFOX6) 
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FOLFOX6 FOLFIRI pathway for 
ambulatory treatment 
(30) NCCN guidelines: National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology (NCCN Guidelines). Colon cancer. Version 2.2015.[Online]. Accessed on Feb 
5th 2015. http://www.tri-kobe.org/nccn/guideline/colorectal/english/colon.pdf 
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Appropriate pump filling 
(31) Pump filling. Digital photograph. Accessed on 16th May 2015. https://www.youtube.com/watch?v=b42BpvnSvuo 
Needle free 
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(32) Pump filling. Digital photograph. Accessed on 16th May 2015. https://www.youtube.com/watch?v=CB3Mde8iEiI  
Resistance 
upon filling the 
pump avoid 
pressure on 
wrist 
(Occupational 
Injury) 
Appropriate pump filling 
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Patient counselling 
(6) Baxter Elastomeric Pumps. Clinician Guide”. Baxter. Health Technology Safety Research Team. N.d. Web. Retrieved July 1st 2014 from: http://www.capca.ca/wp-
content/uploads/Baxter-Elastomeric-Pumps-Clinician-Guide11.pdf 
Monitor pump 
emptying 
depending on 
flow rate of 
pump (e.g. 
2ml/hr , check 
20 mL decrease 
after 10 hours)  
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(33) ) NIOSH [2014]. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2014. By Connor TH, MacKenzie BA, DeBord DG, Trout DB, O’Callaghan JP.. 
Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) 
Publication No. 2014-138 (Supersedes 2012-150) 
(34) The Royal Children’s hospital Melbourne. Cytotoxic materials are identified by a purple symbol representing a cell in late telophase. Accessed on 17th May 2015. 
http://www.rch.org.au/rchcpg/hospital_clinical_guideline_index/Cytotoxic_Drugs_The_Management_Of/ 
 Cytotoxic drugs used to treat 
cancer are classified as 
hazardous 
 Avoid exposing other than 
patient to contents of pump 
 Carefully clean spill 
 Disconnection at hospital 
Patient counselling 
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     Do not submerge pump in water 
     Do not expose to water stream 
  Wrap in plastic bag 
 
  Exercise after consulting your 
healthcare provider 
 Keep pump at room temperature 
  Keep pump at same height of 
catheter connection 
 Keep under pillow 
    Do not place above the head 
(6) Baxter Elastomeric Pumps. Clinician Guide”. Baxter. Health Technology Safety Research Team. N.d. Web. Retrieved July 1st 2014 from: http://www.capca.ca/wp-
content/uploads/Baxter-Elastomeric-Pumps-Clinician-Guide11.pdf 
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The future 
In need of stability data to move more 
antineoplastic drugs to ambulatory setting 
 
Stability profiles extended to days thus 
saving hospital trips to get the next dose 
(35) Salman D, Barton S, Gebara SN. Improving the stability of anticancer drugs. J Oncol Pharm Pract. 2014 Jun;20(3):236 
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The use in Lebanon 
Qualitative study performed with stakeholders in Lebanon 
 Increase awareness and education to all 
healthcare professionals 
 Patient counselling (leaflets) 
 Update the reimbursement schemes to 
incorporate ambulatory chemotherapy 
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